Navigation Links
KAIST's successful transfer of green technology
Date:12/1/2011

Daejeon, Republic of Korea, December 1, 2011The Korea Advanced Institute of Science and Technology (KAIST) has reaped the fruits of its hard work in developing an innovative green technology that will benefit all industries, including public transit application. The technology is called "On-line Electric Vehicle (OLEV)," and not too soon, it will be a daily commuting transport in a city in the US.

OLEV is a pure electric vehicle, receiving electric power wirelessly via magnetic field from the road surface, under which power strips are buried. OLEV charges as it moves, thus no need of additional time and space for recharging.

For the first time in the US, OLEV will be made available to the public for daily use. The City of McAllen, Texas, announced on November 21, 2011 that the city was awarded with $1.9 million grant from the Federal Transit Administration (FTA), U.S. Department of Transportation (DOT), through TIGGER III (Transit Investment in Greenhouse Gas and Energy Reduction) fund. The FTA selected McAllen's bus project from among 266 applications submitted to the TIGGER III Grant Program, which awarded $112 million to 46 projects nationwide. In addition to the grant, the city will match with $211,000 to support the OLEV project.

OLEV Technologies, Inc., a Massachusetts based start-up that commercializes OLEV (On-line Electric Vehicle) technology in the Americas, is responsible for implementing McAllen's OLEV project. KAIST granted the company an exclusive license to commercialize OLEV technology in March this year. OLEV Technologies, Inc. anticipates that the McAllen project will be launched in 2012 and completed by early 2013.

President Nam-Pyo Suh of KAIST said, "We are excited to learn that McAllen City will add OLEV buses to their public transportation services in order to make the city cleaner and greener and to improve energy efficiency. This is certainly an encouraging endeavor for other communities around the world to emulate. On our side, we will continuously perform research and development on OLEV's core technology applying the SMFIR (Shaped Magnetic Field in Resonance) principle so that we can expand its application to railway, consumer electronics, and other various industries."

Dr. Hikyu Lee, President and CEO of OLEV Technologies, Inc. said, "This project will demonstrate the overall effectiveness of using enroute-charging technology to create an effective 'electronic roadway', as well as the cost effective means of converting existing diesel buses into electric vehicles. We are delighted that our technology has been selected for funding to showcase the near-term and long-term benefits of electric buses via wireless power transfer technology, a zero emission green transportation solution."

According to Lee, this project will result in an annual greenhouse gas reduction of 289 tons of CO2, with a total reduction in CO2 of 3,455 tons over the lifetime of the operation of OLEV buses. Expected annual energy savings will amount to 2,596 Million BTUs, with a total 31,149 Million BTUs saved over the same period.

"Using the cutting edge technology to help our residents with transportation is very exciting," said McAllen Mayor Richard Cortez. "It is an honor to be selected for such a competitive grant, and we are very appreciative of our Congressman Henry Cuellar's efforts to secure these funds for McAllen. This is a big investment that will pay off for all of us," added Mayor Cortez.

KAIST initiated the R&D effort on OLEV in May 2009, and since then, various prototype vehicles including bus, sedan, SUV, and tram have been built and demonstrated. Upon successful completion of field tests, three on-line electric trams are commercially operating at a theme park in Seoul, South Korea, since July 2011. The fully electric tram, consisting of three cars, can carry up to 100 passengers per ride.


'/>"/>

Contact: Lan Yoon
hlyoon@kaist.ac.kr
82-423-502-295-82102
The Korea Advanced Institute of Science and Technology (KAIST)
Source:Eurekalert  

Related biology news :

1. Biodegradable mulches successfully control weeds in container-grown arborvitae
2. Teaching skills key to selection of a successful model farmer
3. National Institutes of Health renews successful infectious disease research study
4. Exonhit and BGI announce successful completion of a promising next-generation sequencing project
5. New substance may allow successful transplantation of marginal livers
6. Successful strategy developed to regenerate blood vessels
7. LSUHSC reports first successful salivary stone removal with robotics
8. Successful mothers get help from their friends: Dolphin study
9. Almac has Successful MHRA Inspection at its Clinical Services UK Site
10. University of Nevada, Reno, demonstrates successful sludge-to-power research
11. University of Nevada, Reno demonstrates successful sludge-to-power research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
KAIST's successful transfer of green technology
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... ... ... Back pain relief technology is now available without a prescription at What ... relief for WAR members. , This spinal restoration platform boasts utilization of technology that ... suffering from chronic back pain. , What A Relief Back Pain Centers ...
(Date:1/11/2017)... , PITTSBURGH and BENGALURU, ... (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, ... Drug Administration (FDA) has accepted Mylan,s biologics license application ... through the 351(k) pathway. This product is a proposed ... certain HER2-positive breast cancers. The anticipated FDA goal date ...
(Date:1/11/2017)... , Jan. 11, 2017  GenVec, Inc. ... delivery company, announced today that its chief scientific ... a talk entitled  "AdenoVerse™ platform for translational development ... Biotech Showcase at the upcoming Phacilitate Cell & ... Miami , Florida.  Dr. Brough,s presentation will ...
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... ... signed a multi-year license agreement with Poseida Therapeutics Inc, the San Diego based ... genetic data. Poseida Therapeutics selected KBioBox in order to harness KBioBox’s powerful BioEngine ...
Breaking Biology Technology: